Drugs / inactivated poliovirus vaccine, Sabin strain
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT07354269 | Sep 2025 → Apr 2026 overdue | poliomyelitis | Sinovac Biotech Co., Ltd | Recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | inactivated poliovirus vaccine, Sabin strain | “adolescents and adults aged 7-50 years will receive one dose of sIPV (inactivated poliovirus vaccine, Sabin strain) on Day 0” NCT07354269 ↗ |
| Known as | sIPV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07354269 ↗ |
| Modality | Vaccine | “one dose of sIPV (inactivated poliovirus vaccine, Sabin strain)” NCT07354269 ↗ |
| Route | Intramuscular | “one dose of sIPV administered via intramuscular injection” NCT07354269 ↗ |